human umbilical cord mesenchymal stem cells
AssetAlso called Human Umbilical Cord Mesenchymal Stem Cells Injection, UC-MSC, hUC-MSC, Human Umbilical Cord-Mesenchymal Stem Cells
Allogeneic umbilical cord-derived mesenchymal stem cells for retinal tissue support and regeneration
- Stage
- Phase 2
- Modality
- Cell therapy
- Target
- Not known
- 18
- Indications
- 32
- Trials
- 7
- Developers
3 trials are still running. Trial NCT07628933 started on Jun 30, 2026. clinicaltrials.gov
Indications
18Decompensated liver cirrhosis
Phase 2, Unknown, NCT03529136, clinicaltrials.gov, Oct 24, 2026
Acute ischemic stroke
Phase 1, Not yet recruiting, NCT07628933, clinicaltrials.gov, Oct 24, 2026
Ais
Phase 1, Not yet recruiting, NCT07628933, clinicaltrials.gov, Oct 24, 2026
15 more
In the full profile
- Owner and partners7
- Trials32
- Evidence for its targets1
- Competitors12
- Aging relevance2
- Signals11
Every asset’s record: target, stage, trials and the evidence behind it.